HCV New Drugs

Journal of the International AIDS Society

Published on behalf of the International AIDS Society

Special Issue: Towards global viral hepatitis elimination for all patients in all income settings
Guest Editors: Marina B Klein, Karine Lacombe

The complete supplement file is available at

http://www.iasociety.org/Web/WebContent/File/JIAS_Vol21-S2_complete_file.pdf

Reviews
Open Access
What do clinicians need to watch for with direct‐acting antiviral therapy?
Alessio Aghemo Lionel Piroth Sanjay Bhagani e25076
First Published: 10 April 2018
Abstract
Full text
PDF

Editorial
Open Access
The Rocky Road to viral hepatitis elimination: assuring access to antiviral therapy for ALL coinfected patients from low‐ to high‐income settings
Karine Lacombe Marina B Klein e25073

First Published: 10 April 2018
Full text
PDF

Commentary
Open Access
How far are we from viral hepatitis elimination service coverage targets?
Yvan J‐F Hutin Marc Bulterys Gottfried O Hirnschall e25050
First Published: 10 April 2018
Abstract
Full text
PDF

Research Articles
Open Access
Hep‐CORE: a cross‐sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017
Jeffrey V Lazarus Samya R Stumo Magdalena Harris Greet Hendrickx Kristina L Hetherington
Mojca Maticic Marie Jauffret‐Roustide Joan Tallada Kaarlo Simojoki Tatjana Reic Kelly Safreed‐Harmon the Hep‐CORE Study Group e25052
First Published: 10 April 2018
Abstract
Full text
PDF

Reviews
Open Access
Approaches for simplified HCV diagnostic algorithms
Slim Fourati Jordan J Feld Stéphane Chevaliez Niklas Luhmann e25058
First Published: 10 April 2018
Abstract
Full text
PDF

Research
Open Access
Linkage and retention in HCV care for HIV‐infected populations: early data from the DAA era
Rachel Sacks‐Davis Joseph S Doyle Andri Rauch Charles Beguelin Alisa E Pedrana Gail V Matthews Maria Prins Marc van der Valk Marina B Klein Sahar Saeed Karine Lacombe
Nikoloz Chkhartishvili Frederick L Altice Margaret E Hellard e25051
First Published: 10 April 2018
Abstract
Full text
PDF

Commentary
Open Access
Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low‐ to high‐income settings: making sure no one is left behind
Céline Grillon Priti R Krishtel Othoman Mellouk Anton Basenko James Freeman Luís Mendão
Isabelle Andrieux‐Meyer Sébastien Morin e25060
First Published: 10 April 2018
Abstract
Full text
PDF 

Research
Open Access
Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?
Natasha K Martin Anne Boerekamps Andrew M Hill Bart J A Rijnders e25062
First Published: 10 April 2018
Abstract
Full text
PDF

Commentary
Open Access
Research gaps in viral hepatitis
Anders Boyd Léa Duchesne Karine Lacombe e25054
First Published: 10 April 2018
Abstract
Full text
PDF